Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to collect long term safety data of indacaterol (300 µg o.d.) in
Japanese patients with moderate to severe COPD. Data from this study will be used for the
registration of indacaterol in Japan.